Healthcare Robotics Maker Corindus Is Hiring Engineers after $1B+ Acquisition

by Tatum Hunter
October 31, 2019
Corindus biotech healthtech jobs Boston
photo via shutterstock

Corindus Vascular Robotics is growing its 85-person Boston team by at least a third following its $1.1 billion acquisition by German healthcare company Siemens Healthineers AG, Corindus CEO Mark Toland told Boston Business Journal.

Corindus makes a robotics-assisted platform for placing stents during heart surgeries. It’s currently the only robotics system for such procedures that’s approved by the U.S. Food and Drug Administration. 

The system, called CorPath GRX, lets surgeons position stents by guiding a robotic arm using joysticks and touchscreens. Because they can sit at a station instead of standing over their patients, they’re partially protected from radiation and joint damage, and their patients benefit from increased precision and more efficient workflow during surgery.

Corindus will remain based in Boston, and Toland will stay on to lead the business unit. The company’s public stock was delisted after the Tuesday acquisition. 

Corindus has 12 open roles on its website at the time of this writing. Toland said the company will focus on investing in engineering talent.

Jobs at Corindus

Boston startup guides

LOCAL GUIDE
Best Companies to Work for in Boston
LOCAL GUIDE
Coolest Tech Offices in Boston
LOCAL GUIDE
Best Perks at Boston Tech Companies
LOCAL GUIDE
Women in Boston Tech